NEW DELHI : Government will soon start phase III trial of drug for treatment of covid-19 which is mainly used for treatment of influenza and is available in China and Russia.
The drug has recently come into prominence due to its potential use for Covid-19 patients.Council of Scientific and Industrial Research (CSIR) constituent lab CSIR-Central Drug Research Institute(CDRI) Lucknow has received Drugs Controller General of India (DCGI) approval for carrying out Phase III randomised, Double blind, Placebo controlled trial of efficacy, safety and tolerability of antiviral drug Umifenovir.The Phase III Clinical Trials will be carried out at King George's Medical University (KGMU), Dr.